Project Grant F32AI178962

Award Date 12/10/24
Completion Date 7/31/27
Dollars Obligated $163K
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Minneapolis, MN 55455, USA
Similar Awards
This $107,948 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will fund research to investigate the local and systemic coordination of antiviral immunity by tissue-resident memory CD8 T cells in the skin. The two-year project, running from February 1, 2025 to August 25, 2027, aims to determine whether CD8 tissue-resident memory T cells in the skin can orchestrate an immune...
This $380,320 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support research by the Trustees of the University of Pennsylvania to elucidate the lineage dynamics of optimal human CD8 T cell responses to SARS-CoV-2 and how CD8 T cell homeostasis is altered in Long COVID. The key products of this 3-year project include: Defining human memory CD8 T cell differentiation...
The federal Project Grant award R21AI182804 was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) to support research on the regulation of metabolic adaptation in effector CD8 T cells during chronic viral infection. The $189,713 award, effective from November 12, 2024 to October 31, 2026, will be conducted by Northwestern University to investigate the role of the IL-21-PIM1 signaling axis in...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $639,084 to the Children's Hospital Medical Center in Cincinnati, Ohio to conduct research on the heterogeneity of naive CD8 T cells and their role in immune response and homeostasis. The research aims to elucidate how naive CD8 T cell heterogeneity contributes to protective immunity against pathogens and...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $640,735.00 to Emory University to conduct research on understanding the mechanisms of CD8+ tissue-resident memory T cells (TRM) that mediate protection against respiratory virus transmission. The research aims to investigate the characteristics, durability, and molecular mechanisms of respiratory tract TRM...
This federal Project Grant award of $658,657, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to understand the biophysical and functional coupling of protein condensates to ordered lipid domains in T-cells. The principal investigator from the University of Virginia will lead this 5-year research project, collaborating with a subrecipient, The Hospital for Sick Children, to...
This federal Project Grant award of $192,888 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to evaluate the generation, differentiation, breadth, and persistence of SARS-CoV-2-specific CD4+ and CD8+ T cell responses in non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL) patients after vaccination and infection. The goal is to provide in-depth knowledge of...
This federal Project Grant award, totaling $472,210.00, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The purpose of the award is to investigate the spatiotemporal relationship between CD4+ T resident memory cells and neutrophil recruitment in the lungs during pneumonia, while developing a transcriptional atlas of immune processes in the experienced lung. Key objectives include...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $693,465 to Cornell University to conduct research on mapping infant and adult T cell immunity. The project aims to construct the first molecular atlas of T cell development in lymph nodes and determine how cellular interactions and communication networks change during CD8+ T cell priming throughout...
This Project Grant award, valued at $735,078, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award aims to unravel the molecular mechanisms of innate immune memory in humans, specifically focused on understanding the epigenetic changes and genetic factors underlying trained immunity in myeloid and lymphoid progenitor cells. The research will use single-cell gene expression and...

This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), is providing $162,512 to the Regents of the University of Minnesota to investigate the factors that support the expansion and function of long-lived effector CD8 T cells within the memory compartment.

The key objectives are to determine what pro-inflammatory cytokines and other factors promote the formation and persistence of these long-lived effector CD8 T cells, as well as how exposing mice to a broader range of pathogens alters the function of these cells and their ability to respond to systemic and local infections. The research leverages RNA sequencing and CRISPR genetic knockout techniques to identify the critical mechanisms driving this T cell population. Findings from this 3-year project will yield important insights into the impacts of pathogen exposure and inflammation on the CD8 T cell memory compartment, which can inform the development of more effective vaccines and T cell therapies.

Generated 7/1/25, 5:51 AM